Description

Suhagra-25 (Sildenafil Citrate 25 mg) – Product Description

Overview

Suhagra-25 is a pharmaceutical formulation containing Sildenafil Citrate 25 mg, manufactured by Cipla Ltd., a globally recognized pharmaceutical company. Each pack contains 4 tablets, with each tablet delivering 25 mg of the active ingredient Sildenafil Citrate. Suhagra-25 belongs to the class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, indicated for the treatment of erectile dysfunction (ED) in adult men.

Sildenafil Citrate, the active substance in Suhagra-25, is the same compound that has been extensively studied and approved by regulatory authorities worldwide for the management of erectile dysfunction. The U.S. Food and Drug Administration (FDA) initially approved sildenafil citrate for this indication in 1998, establishing its efficacy and safety profile through rigorous clinical trials.

Mechanism of Action

Suhagra-25 works through a well-established physiological mechanism. During sexual stimulation, nitric oxide (NO) is released in the corpus cavernosum of the penis. This nitric oxide activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP). The accumulation of cGMP produces smooth muscle relaxation in the corpus cavernosum, allowing increased blood flow into the penis and facilitating an erection.

Sildenafil citrate enhances this natural physiological process by selectively inhibiting phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cGMP in the corpus cavernosum. By blocking PDE5, sildenafil allows cGMP levels to remain elevated, thereby prolonging and enhancing the erectile response to sexual stimulation. Importantly, sildenafil has no direct relaxant effect on the corpus cavernosum and does not produce an erection in the absence of sexual stimulation.

Clinical Efficacy

Clinical studies have demonstrated that sildenafil citrate produces statistically significant improvement compared to placebo in the treatment of erectile dysfunction. Across multiple clinical trials, sildenafil citrate has shown consistent efficacy across various patient populations, including those with underlying medical conditions that may contribute to erectile dysfunction. The 25 mg dosage strength represents the lowest approved dose, suitable for patients who may require dose adjustment based on individual tolerability and response.

Dosage and Administration

Suhagra-25 should be taken as directed by a healthcare professional. The recommended dose for most patients is 50 mg taken as needed approximately one hour before sexual activity. However, based on individual effectiveness and tolerability, the dose may be adjusted to 25 mg or increased to a maximum of 100 mg.

Suhagra-25 may be taken anywhere from 30 minutes to 4 hours before sexual activity. The tablet should be swallowed whole with water and may be taken with or without food. However, consumption of a heavy or high-fat meal may delay the onset of action. The maximum recommended dosing frequency is once per day.

Contraindications and Warnings

Suhagra-25 is contraindicated in patients who are using nitric oxide donors, such as organic nitrates or organic nitrites in any form (including nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate). Administration of sildenafil with nitrates has been shown to potentiate the hypotensive effects of nitrates, creating a significant risk of severe hypotension. Concurrent use of sildenafil with guanylate cyclase stimulators such as riociguat is also contraindicated.

Patients with known hypersensitivity to sildenafil or any component of the tablet should not use this medication. Sildenafil is not indicated for use in women or children.

Adverse Reactions

The most common adverse reactions reported with sildenafil citrate include headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash. These effects are generally mild to moderate in severity and often resolve as the body adjusts to the medication. Patients should consult their healthcare provider if side effects persist or become bothersome.

Product Specifications

---

Top 10 Frequently Asked Questions

1. What is Suhagra-25 used for?

Suhagra-25 is used for the treatment of erectile dysfunction (ED) in adult men. It helps increase blood flow to the penis, enabling men to achieve and maintain an erection sufficient for sexual activity when sexually stimulated.

2. How does Suhagra-25 work?

Suhagra-25 contains sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor. It works by inhibiting the PDE5 enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP) in the penis. This allows cGMP levels to remain elevated, promoting smooth muscle relaxation and increased blood flow to the corpus cavernosum during sexual stimulation.

3. How should I take Suhagra-25?

Take Suhagra-25 as prescribed by your doctor. The tablet should be swallowed whole with water, approximately one hour before sexual activity. It can be taken anywhere from 30 minutes to 4 hours before sexual activity. Do not take more than one dose in a 24-hour period.

4. Can I take Suhagra-25 with food?

Suhagra-25 may be taken with or without food. However, consuming a heavy or high-fat meal may delay the absorption of the medication and prolong the time it takes to become effective.

5. What are the common side effects of Suhagra-25?

Common side effects include headache, flushing, dyspepsia (indigestion), nasal congestion, dizziness, abnormal vision (including blurred vision and changes in color perception), back pain, muscle pain, and nausea. These side effects are typically mild and transient.

6. Who should not take Suhagra-25?

Suhagra-25 should not be taken by individuals who are using nitrate medications (such as nitroglycerin or isosorbide dinitrate) for chest pain or heart conditions, as this combination can cause a dangerous drop in blood pressure. It is also contraindicated in patients with known hypersensitivity to sildenafil or any tablet components, and in patients taking guanylate cyclase stimulators such as riociguat.

7. Can I take Suhagra-25 if I have heart problems?

Patients with cardiovascular disease should consult their healthcare provider before using Suhagra-25. Sexual activity itself poses a cardiac risk, and sildenafil should not be used if sexual activity is inadvisable due to cardiovascular status. Patients who have had a heart attack in the past 3 months or stroke or heart failure in the past 6 months should not take this medication.

8. Can Suhagra-25 be used for premature ejaculation?

No, Suhagra-25 is not indicated for the treatment of premature ejaculation. It is specifically approved for the treatment of erectile dysfunction (the inability to achieve or maintain an erection sufficient for sexual activity).

9. How long does Suhagra-25 take to work?

Suhagra-25 typically begins to work within 30 to 60 minutes after oral administration. The onset of action may vary from person to person, and the medication will only be effective in the presence of sexual stimulation.

10. Is Suhagra-25 available without a prescription?

No, Suhagra-25 is a prescription medication. It should only be taken under the supervision and guidance of a qualified healthcare professional who can assess your medical history, evaluate potential drug interactions, and determine the appropriate dosage for your individual needs.

---

Important Safety Information

Suhagra-25 should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis, or Peyronie’s disease), conditions that may predispose to priapism (such as sickle cell anemia, multiple myeloma, or leukemia), bleeding disorders, or active peptic ulcer disease.

Patients should seek immediate medical attention if they experience chest pain, sudden vision loss, sudden hearing loss, or an erection that persists for more than 4 hours (priapism).

Alcohol consumption may increase the likelihood of side effects such as dizziness and may reduce the ability to achieve an erection. Patients should avoid driving or operating machinery if they experience dizziness or visual disturbances after taking this medication.

Storage Instructions

Store Suhagra-25 at room temperature (below 25 degrees Celsius), protected from moisture and light. Keep the tablets in the original packaging and out of the reach of children.

---

References and Reputable Sources

The information provided in this product description is supported by authoritative sources:

• U.S. Food and Drug Administration (FDA) – Sildenafil Label Information: https://www.accessdata.fda.gov

• DailyMed – Sildenafil Tablets Prescribing Information: https://dailymed.nlm.nih.gov

• National Library of Medicine – Sildenafil Mechanism of Action: https://www.ncbi.nlm.nih.gov

• ClinicalTrials.gov – Sildenafil Clinical Studies: https://clinicaltrials.gov

• PubMed – Comparative Efficacy Studies: https://pubmed.ncbi.nlm.nih.gov

---

Suhagra-25 offers a reliable, clinically proven option for men seeking effective management of erectile dysfunction. Manufactured by Cipla, a trusted name in global pharmaceuticals, this product delivers the active ingredient sildenafil citrate in a convenient 25 mg dosage strength.

To purchase Suhagra-25 and learn more about this product, please visit our secure online store at:

https://anabolicsteroidsonline.shop/